2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders

Details for Australian Patent Application No. 2004264382 (hide)

Owner Novartis AG IRM LLC

Inventors Ohmori, Osamu; Jiang, Jiqing; Chopiuk, Greg; Gray, Nathanael Schiander; Kawahara, Eiji; Umemura, Ichiro; Masuya, Keiichi; Zhang, Qiong; Ding, Qiang; Steensma, Ruo; Matsuura, Naoko; Kanazawa, Takanori; Wan, Yongqin; Miyake, Takahiro; GarciaEcheverria, Carlos; Karanewsky, Donald

Agent Davies Collison Cave

Pub. Number AU-A-2004264382

PCT Pub. Number WO2005/016894

Priority 0322370.8 24.09.03 GB; 0319227.5 15.08.03 GB

Filing date 13 August 2004

Wipo publication date 24 February 2005

International Classifications

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016894 Priority application(s): WO2005/016894

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264387-3H-phenoxazine derivatives suitable as near-infrared imaging agents, preparation and use thereof

2004264372-CD20-binding polypeptide compositions